• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥地利女性乳腺癌中P53突变的新模式。

Novel pattern of P53 mutation in breast cancers from Austrian women.

作者信息

Hartmann A, Rosanelli G, Blaszyk H, Cunningham J M, McGovern R M, Schroeder J J, Schaid D J, Kovach J S, Sommer S S

机构信息

Department of Oncology, Mayo Clinic, Rochester, Minnesota 55905.

出版信息

J Clin Invest. 1995 Feb;95(2):686-9. doi: 10.1172/JCI117714.

DOI:10.1172/JCI117714
PMID:7598762
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC295535/
Abstract

Since mutagens produce an extraordinary diversity of mutational patterns, differential mutational exposures among populations are expected to produce different patterns of mutation. Classical epidemiological methods have been successful in implicating specific mutagens in cancers such as those of lung and skin in which one mutagen predominates. In breast cancer, however, no mutagens have been implicated in an unequivocal manner. In an attempt to facilitate epidemiological studies, we have been studying the pattern of p53 gene mutations in breast cancers from multiple populations with high and low breast cancer incidences. We previously reported that breast cancers from Midwest United States, predominantly rural Caucasian women, have a different pattern of p53 gene mutation from populations of Western European women. Herein, we analyze patterns of p53 mutations from Graz, Austria, another population with a high incidence of breast cancer. Among the 60 Austrian breast cancers analyzed, 14 (23%) have a p53 gene mutation in exons 5-9 or in adjacent splice junctions. Analysis of the patterns of mutation shows differences between the "Western European" profile and the Austrian and Midwest United States groups (P = 0.027 and 0.024, respectively). The Austrian pattern is characterized by a high frequency of A:T-->T:A transversions (P = 0.006). The presence of distinct patterns of mutation among the limited number of analyzed populations of Western European origin supports the idea that differential mutagenic exposure and/or genetic differences contribute to breast cancer mutagenesis among geographically distinct Caucasians of Western European origin.

摘要

由于诱变剂会产生多种多样的突变模式,因此预计不同人群之间不同的诱变暴露会产生不同的突变模式。经典流行病学方法已成功地将特定诱变剂与某些癌症联系起来,比如在肺癌和皮肤癌中,有一种诱变剂占主导地位。然而,在乳腺癌中,尚未明确指出任何诱变剂。为了促进流行病学研究,我们一直在研究来自乳腺癌发病率高低不同的多个群体的乳腺癌中p53基因突变模式。我们之前报道过,来自美国中西部(主要是农村白人女性)的乳腺癌与西欧女性群体的p53基因突变模式不同。在此,我们分析了来自奥地利格拉茨的p53基因突变模式,这是另一个乳腺癌高发群体。在分析的60例奥地利乳腺癌中,有14例(23%)在外显子5 - 9或相邻剪接位点存在p53基因突变。对突变模式的分析表明,“西欧”模式与奥地利及美国中西部群体之间存在差异(P值分别为0.027和0.024)。奥地利模式的特点是A:T→T:A颠换频率较高(P = 0.006)。在有限数量的西欧裔分析群体中存在不同的突变模式,这支持了以下观点:不同的诱变暴露和/或基因差异导致了西欧裔地理上不同的白种人之间乳腺癌的诱变发生。

相似文献

1
Novel pattern of P53 mutation in breast cancers from Austrian women.奥地利女性乳腺癌中P53突变的新模式。
J Clin Invest. 1995 Feb;95(2):686-9. doi: 10.1172/JCI117714.
2
p53 mutations and overexpression in locally advanced breast cancers.局部晚期乳腺癌中的p53突变与过表达
Br J Cancer. 1994 Jun;69(6):1145-50. doi: 10.1038/bjc.1994.225.
3
Pattern of p53 gene mutations in breast cancers of women of the midwestern United States.美国中西部女性乳腺癌中p53基因突变模式
J Natl Cancer Inst. 1992 Feb 19;84(4):246-52. doi: 10.1093/jnci/84.4.246.
4
High frequency of p53 gene mutations in primary breast cancers in Japanese women, a low-incidence population.日本女性(乳腺癌低发人群)原发性乳腺癌中p53基因突变的高频率。
Br J Cancer. 1996 Apr;73(8):896-901. doi: 10.1038/bjc.1996.179.
5
p53 gene mutations inside and outside of exons 5-8: the patterns differ in breast and other cancers.第5至8外显子内外的p53基因突变:乳腺癌与其他癌症中的模式有所不同。
Oncogene. 1995 Feb 16;10(4):681-8.
6
Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value.通过高灵敏度方法进行的突变检测表明,乳腺癌中的p53基因突变可能具有重要的预后价值。
Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1093-6. doi: 10.1073/pnas.93.3.1093.
7
Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.印度乳腺癌中p53、fhit、p16INK4a/p19ARF和H-ras基因的突变谱
Int J Oncol. 2000 Nov;17(5):1031-5. doi: 10.3892/ijo.17.5.1031.
8
Low frequency of p53 gene mutations in breast cancers of Japanese-American women.日裔美国女性乳腺癌中p53基因突变的低频率
Nutr Cancer. 2001;39(1):72-7. doi: 10.1207/S15327914nc391_10.
9
Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.肿瘤抑制基因p53的突变在外阴癌细胞中经常被发现。
Am J Obstet Gynecol. 1995 Nov;173(5):1477-82. doi: 10.1016/0002-9378(95)90636-3.
10
Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.两种不同的机制会改变乳腺癌中的p53:突变和核排除。
Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):7262-6. doi: 10.1073/pnas.89.15.7262.

引用本文的文献

1
Low expression of leptin and its association with breast cancer: A transcriptomic study.瘦素的低表达及其与乳腺癌的关联:一项转录组学研究。
Oncol Rep. 2016 Jul;36(1):43-8. doi: 10.3892/or.2016.4806. Epub 2016 May 13.
2
Transcriptomics profiling study of breast cancer from Kingdom of Saudi Arabia revealed altered expression of Adiponectin and Fatty Acid Binding Protein4: Is lipid metabolism associated with breast cancer?沙特阿拉伯王国乳腺癌的转录组学分析研究揭示了脂联素和脂肪酸结合蛋白4的表达改变:脂质代谢与乳腺癌有关吗?
BMC Genomics. 2015;16 Suppl 1(Suppl 1):S11. doi: 10.1186/1471-2164-16-S1-S11. Epub 2015 Jan 15.
3
HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer.结直肠癌中HER2、TOP2A、CCND1、EGFR和C-MYC癌基因扩增
J Clin Pathol. 2007 Jul;60(7):768-72. doi: 10.1136/jcp.2006.038281. Epub 2006 Aug 1.
4
P53 mutations associated with breast, colorectal, liver, lung, and ovarian cancers.P53突变与乳腺癌、结直肠癌、肝癌、肺癌和卵巢癌相关。
Environ Health Perspect. 1996 Dec;104(12):1324-31. doi: 10.1289/ehp.961041324.
5
Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects.人类肿瘤和细胞系中p53基因体细胞突变数据库:最新汇编与未来展望
Nucleic Acids Res. 1997 Jan 1;25(1):151-7. doi: 10.1093/nar/25.1.151.
6
High frequency of p53 gene mutations in primary breast cancers in Japanese women, a low-incidence population.日本女性(乳腺癌低发人群)原发性乳腺癌中p53基因突变的高频率。
Br J Cancer. 1996 Apr;73(8):896-901. doi: 10.1038/bjc.1996.179.

本文引用的文献

1
Germline mutations in the factor IX gene: a comparison of the pattern in Caucasians and non-Caucasians.凝血因子IX基因的种系突变:白种人与非白种人突变模式的比较。
Hum Mol Genet. 1993 Mar;2(3):293-8. doi: 10.1093/hmg/2.3.293.
2
Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor.冰岛人群中人类乳腺癌的体细胞p53突变:一种预后因素。
Cancer Res. 1993 Apr 1;53(7):1637-41.
3
p53 gene mutations in human epithelial skin cancers.人类上皮性皮肤癌中的p53基因突变
Oncogene. 1993 Mar;8(3):583-8.
4
Cancer statistics, 1993.1993年癌症统计数据。
CA Cancer J Clin. 1993 Jan-Feb;43(1):7-26. doi: 10.3322/canjclin.43.1.7.
5
Clinical implications of the p53 tumor-suppressor gene.p53肿瘤抑制基因的临床意义。
N Engl J Med. 1993 Oct 28;329(18):1318-27. doi: 10.1056/NEJM199310283291807.
6
Does a genotoxic carcinogen contribute to human breast cancer? The value of mutational spectra in unravelling the aetiology of cancer.基因毒性致癌物会导致人类乳腺癌吗?突变谱在揭示癌症病因方面的价值。
Mutagenesis. 1993 Jul;8(4):275-83. doi: 10.1093/mutage/8.4.275.
7
Migration patterns and breast cancer risk in Asian-American women.亚裔美国女性的移民模式与乳腺癌风险
J Natl Cancer Inst. 1993 Nov 17;85(22):1819-27. doi: 10.1093/jnci/85.22.1819.
8
Prognostic significance of TP53 alterations in breast carcinoma.TP53基因改变在乳腺癌中的预后意义
Br J Cancer. 1993 Sep;68(3):540-8. doi: 10.1038/bjc.1993.383.
9
Novel pattern of p53 gene mutations in an American black cohort with high mortality from breast cancer.美国一个乳腺癌死亡率高的黑人队列中p53基因突变的新模式。
Lancet. 1994 May 14;343(8907):1195-7. doi: 10.1016/s0140-6736(94)92403-1.
10
Molecular analysis of ethylene oxide-induced mutations at the HPRT locus in human diploid fibroblasts.人二倍体成纤维细胞中环氧乙烷诱导的次黄嘌呤-鸟嘌呤磷酸核糖转移酶(HPRT)基因座突变的分子分析。
Mutat Res. 1993 Jun;287(2):283-92. doi: 10.1016/0027-5107(93)90021-7.